Taking aim at protein translation in AML

被引：3

作者：

Carroll, Martin ^{[1
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

来源：

BLOOD | 2009年 / 114卷 / 08期

关键词：

MTOR;

D O I：

10.1182/blood-2009-06-224220

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1458 / 1459

页数：4

共 6 条

[1] Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy [J].

Choo, Andrew Y. ;

Blenis, John .

CELL CYCLE, 2009, 8 (04) :567-572

[2] eIF4E is a central node of an RNA regulon that governs cellular proliferation [J].

Culjkovic, Biljana ;

Topisirovic, Ivan ;

Skrabanek, Lucy ;

Ruiz-Gutierrez, Melisa ;

Borden, Katherine L. B. .

JOURNAL OF CELL BIOLOGY, 2006, 175 (03) :415-426

[3] Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G [J].

Moerke, Nathan J. ;

Aktas, Huseyin ;

Chen, Han ;

Cantel, Sonia ;

Reibarkh, Mikhail Y. ;

Fahmy, Amr ;

Gross, John D. ;

Degterev, Alexei ;

Yuan, Junying ;

Chorev, Michael ;

Halperin, Jose A. ;

Wagner, Gerhard .

CELL, 2007, 128 (02) :257-267

[4] Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia [J].

Tamburini, Jerome ;

Green, Alexa S. ;

Bardet, Valerie ;

Chapuis, Nicolas ;

Park, Sophie ;

Willems, Lise ;

Uzunov, Madalina ;

Ifrah, Norbert ;

Dreyfus, Francois ;

Lacombe, Catherine ;

Mayeux, Patrick ;

Bouscary, Didier .

BLOOD, 2009, 114 (08) :1618-1627

[5] Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis [J].

Topisirovic, I ;

Guzman, ML ;

McConnell, MJ ;

Licht, JD ;

Culjkovic, B ;

Neering, SJ ;

Jordan, CT ;

Borden, KLB .

MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :8992-9002

[6] mTOR regulates cell survival after etoposide treatment in primary AML cells [J].

Xu, Q ;

Thompson, JE ;

Carroll, M .

BLOOD, 2005, 106 (13) :4261-4268

← 1 →